AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,000 | -99.3% | 270 | -97.4% | 0.00% | -100.0% |
| Q2 2020 | $139,000 | +231.0% | 10,276 | +90.6% | 0.01% | +200.0% |
| Q1 2020 | $42,000 | +40.0% | 5,391 | +13.7% | 0.00% | +50.0% |
| Q4 2019 | $30,000 | +400.0% | 4,741 | +230.8% | 0.00% | – |
| Q3 2019 | $6,000 | -66.7% | 1,433 | -61.4% | 0.00% | -100.0% |
| Q2 2019 | $18,000 | -5.3% | 3,714 | +12.3% | 0.00% | -50.0% |
| Q4 2018 | $19,000 | +171.4% | 3,308 | +311.4% | 0.00% | +100.0% |
| Q3 2018 | $7,000 | -99.9% | 804 | -1.8% | 0.00% | 0.0% |
| Q2 2018 | $8,174,000 | +817300.0% | 819 | +923.8% | 0.00% | – |
| Q1 2018 | $1,000 | -66.7% | 80 | -63.6% | 0.00% | – |
| Q4 2017 | $3,000 | -40.0% | 220 | -30.6% | 0.00% | – |
| Q2 2017 | $5,000 | -16.7% | 317 | -53.0% | 0.00% | -100.0% |
| Q1 2017 | $6,000 | +200.0% | 674 | +203.6% | 0.00% | – |
| Q4 2016 | $2,000 | – | 222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |